Does Rallies show Form 4 insider transactions for RGC?

Yes. Rallies tracks RGC insider trading and Form 4 activity, including executive purchases, executive sales, transaction dates, shares, and prices when available.

Is RGC research on Rallies investment advice?

No. Rallies provides research, data, and educational context for RGC. It does not provide personalized investment advice.

RGC (Regencell Bioscience Holdings Limited Ordinary Shares) Stock Analysis - Insider Trades

Regencell Bioscience Holdings Limited Ordinary Shares (RGC) is a publicly traded Healthcare sector company. As of May 21, 2026, RGC trades at $27.39 with a market cap of $13.74B and a P/E ratio of 38.67. RGC moved +3.31% today. Year to date, RGC is +1.29%; over the trailing twelve months it is +131.52%. Its 52-week range spans $0.09 to $83.60. Rallies surfaces RGC's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Who is trading RGC stock inside the company?

Recent RGC insider activity includes BELL THOMAS D JR bought 25.00K, KAPLAN STEPHEN A bought 10.00K, Ownby David bought 7.50K, BRANDOW PETER B sold 20.23K, and DUNN GREGORY W sold 26.05K. Rallies tracks insider transaction dates, shares, prices, and estimated values.

RGC Key Metrics

Key financial metrics for RGC
Metric	Value
Price	$27.39
Market Cap	$13.74B
P/E Ratio	38.67
EPS	$0.72
Dividend Yield	0.22%
52-Week High	$83.60
52-Week Low	$0.09
Volume	90
Avg Volume	0
Revenue (TTM)	$3.16B
Net Income	$112.30M
Gross Margin	0.00%

Recent RGC Insider Trades

BELL THOMAS D JR bought 25.00K (~$369.00K) on Aug 29, 2017.
KAPLAN STEPHEN A bought 10.00K (~$148.70K) on Aug 25, 2017.
Ownby David bought 7.50K (~$105.30K) on Aug 24, 2017.
BRANDOW PETER B sold 20.23K (~$455.24K) on Mar 9, 2017.
DUNN GREGORY W sold 26.05K (~$577.01K) on Mar 9, 2017.

Latest RGC News

Regencell (RGC) pops as traders revisit newly filed $500M ATM share-sale program — Apr 30, 2026
Regencell Bioscience (RGC) climbs as class action filing fuels thin-float volatility — Apr 27, 2026
RGC slips as traders refocus on $500 million ATM offering overhang — Apr 26, 2026
Regencell Bioscience slides as traders price in $500 million ATM dilution risk — Apr 25, 2026
Regencell (RGC) falls as $500M ATM offering overhang meets renewed volatility — Apr 24, 2026

RGC Analyst Consensus

RGC analyst coverage data. Average price target: $0.00.

Common questions about RGC

Who is trading RGC stock inside the company?: Recent RGC insider activity includes BELL THOMAS D JR bought 25.00K, KAPLAN STEPHEN A bought 10.00K, Ownby David bought 7.50K, BRANDOW PETER B sold 20.23K, and DUNN GREGORY W sold 26.05K. Rallies tracks insider transaction dates, shares, prices, and estimated values.
Does Rallies show Form 4 insider transactions for RGC?: Yes. Rallies tracks RGC insider trading and Form 4 activity, including executive purchases, executive sales, transaction dates, shares, and prices when available.
Is RGC research on Rallies investment advice?: No. Rallies provides research, data, and educational context for RGC. It does not provide personalized investment advice.